Dr. Catherine Bollard, MD
- Publications
- 267
- Clinical trials
- 10
- Hospital affiliations
- 1
- Industry payments
- $20,378
- Medical group
- 1
- Practice address
- 5255 Loughboro Rd NW, Washington, DC 20016
- Practice phone
- Call (202) 537-4680
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Bollard's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Catherine Bollard is a pediatric hematology and oncology physician in Washington, District of Columbia
Dr. Bollard practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.
Dr. Bollard's NPI, 1639259062, was assigned on October 17, 2006. Dr. Bollard graduated from University of Otago School of Medicine in 1991. Dr. Bollard's Texas license number on file is L9630.
- NPI
- 1639259062NPI Registry (opens in a new tab)
- NPI enumeration date
- October 17, 2006
- NPI status
- Active
- Practice phone
- (202) 537-4680
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Medical school graduation
- 1991
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Catherine Bollard practices at Sibley Memorial Hospital in Washington, District of Columbia
Dr. Bollard's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.
- Sibley Memorial Hospital5255 Loughboro Rd NW, Washington, DC 20016 · The District CountyPhone(202) 537-4680
Source: Dmand AI Affiliation Data
Dr. Catherine Bollard is affiliated with 1 site of care and 1 medical group
Dr. Bollard's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. The medical group on file is Children's National Hospital.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Catherine Bollard's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bollard practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sibley Memorial Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Johns Hopkins Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Catherine Bollard is one of 65 pediatric hematologys and oncology physicians in District of Columbia
Pediatric hematology-oncology is Dr. Bollard's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Bollard is board certified in pediatrics and child health division by the Royal Australian College of Physicans. Dmand AI has Dr. Bollard's licenses on file in 2 states: Texas and District of Columbia.
Specialties and state licenses
- Pediatric hematology and oncology, TexasPrimary
- District of Columbia license
Pediatric hematologys and oncology physicians near Dr. Bollard
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Catherine Bollard's patients have a median age of 8
Across all payers, Dmand AI patient panel data puts Dr. Bollard's median patient age at 8, with 100% women.
Dr. Bollard's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 8
Patient panel by sex, all payers
- Women100%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. Catherine Bollard has 267 publications on record
Dmand AI links 267 papers to Dr. Bollard, published from 2003 to 2025. 2018 was the busiest year, with 12. The most frequent topics are T-Lymphocytes, Hematopoietic Stem Cell Transplantation and Immunotherapy, Adoptive. Dr. Bollard has published most often in Blood. Dr. Bollard's most frequent co-authors are Helen E. Heslop, MD, Malcolm Brenner, MD and Elizabeth J. Shpall, MD.
Dr. Bollard's papers by year, 2016 to 2025
Topics Dr. Bollard writes about most
- T-Lymphocytes
- Hematopoietic Stem Cell Transplantation
- Immunotherapy, Adoptive
- Herpesvirus 4, Human
- T-Lymphocytes, Cytotoxic
- Epstein-Barr Virus Infections
- Graft vs Host Disease
- Immunotherapy
Dr. Bollard's most frequent co-authors
- Helen E. Heslop, MD62 shared papers
- Malcolm Brenner, MD36 shared papers
- Elizabeth J. Shpall, MD33 shared papers
Recent publications by Dr. Bollard
Transplant Cell Ther
Nat Rev Clin Oncol
See who Dr. Bollard researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Bollard works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Catherine Bollard has worked on 10 clinical trials
Dmand AI links Dr. Bollard to 10 clinical trials, 8 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Hodgkin Disease, Adenoviridae Infections and Leiomyosarcoma. Baylor College of Medicine sponsors the most, 4.
Clinical trials with Dr. Bollard by phase
- 8Phase 1: 8 trials
- 2Phase 2: 2 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Bollard's trials
- Hodgkin Disease
- Adenoviridae Infections
- Leiomyosarcoma
- DNA Virus Infections
- Lymphoma, Non-Hodgkin
Investigators on the most trials with Dr. Bollard
- Helen E. Heslop, MD2 shared trials
- Mitchell S. Cairo, MD1 shared trial
- Kenneth Robert Cooke, MD1 shared trial
Recent clinical trials with Dr. Bollard
Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma (opens in a new tab)
3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma (opens in a new tab)
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD (opens in a new tab)
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Catherine Bollard received $20,378 in industry payments from 2017 to 2025
CMS Open Payments shows 26 general payments to Dr. Bollard from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 83% of the total. Swedish Orphan Biovitrum AB paid the most, $7,527. It also lists 16 research payments totaling $15,275 from 2021 to 2024.
General payments to Dr. Bollard by program year, 2017 to 2025
General payments to Dr. Bollard by kind, 2017 to 2025
- Consulting fees$16,88483%
- Food and beverage$2,06610%
- Honoraria$1,1105%
- Travel and lodging$3192%
Companies that paid Dr. Bollard the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Catherine Bollard has 18 awards and honors on record
Dmand AI lists 18 awards for Dr. Bollard, most recently Induction into the Henry Kunkel Society in 2014.
Awards and honors for Dr. Bollard
- 2014
- Induction into the Henry Kunkel Society
- 2011
- Basi Science Award
- 2010
- ASCI Member
- Induction to American Society of Clinical Investigation (ASCI)
- 2009
- Best Abstract Award
- 2007
- Best Oral Presentation
Source: Dmand AI Professional Profile Data
Dr. Catherine Bollard graduated from University of Otago School of Medicine
Dr. Bollard graduated from University of Otago School of Medicine in 1991.
- Medical school
- Board certified in pediatrics and child health division
- Board certified in hematology and immunology
Source: Dmand AI Professional Profile Data
Dr. Catherine Bollard accepts plans from 4 insurance carriers
Dr. Bollard is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, CareFirst BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
- Blue Cross Blue Shield of Michigan
- CareFirst BlueCross BlueShield
- Elevance
- Molina
Plan types Dr. Bollard accepts, by number of carriers
- HMO3
- PPO3
- Medicare2
- POS2
- EPO1
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Catherine Bollard's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Catherine Bollard
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Catherine Bollard's NPI number?
Dr. Catherine Bollard's NPI number is 1639259062. It was assigned on October 17, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Catherine Bollard?
Dr. Catherine Bollard is a pediatric hematology and oncology physician in Washington, District of Columbia. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Catherine Bollard practice?
Dr. Bollard practices at 5255 Loughboro Rd NW, Washington, DC 20016. Dr. Bollard's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.
What is Dr. Catherine Bollard's office phone number?
The practice phone on file for Dr. Bollard is (202) 537-4680.
What is Dr. Catherine Bollard's medical license number?
Dr. Bollard's Texas license number on file is L9630, one of the licenses on file in 2 states.
Which states has Dr. Catherine Bollard been licensed in?
Dmand AI has state licenses on file for Dr. Bollard in Texas (2004 to 2014) and District of Columbia (2013 to 2027).
Which hospitals is Dr. Catherine Bollard affiliated with?
Dr. Bollard practices at Sibley Memorial Hospital in Washington, District of Columbia.
What medical group is Dr. Catherine Bollard part of?
Dr. Bollard is linked to Children's National Hospital.
Is Dr. Catherine Bollard board certified?
Yes. Dr. Bollard is board certified in pediatrics and child health division by the Royal Australian College of Physicans.
Where did Dr. Catherine Bollard go to medical school?
Dr. Bollard graduated from University of Otago School of Medicine in 1991.
Show 5 more questionsShow fewer questions
Has Dr. Catherine Bollard received payments from drug or device companies?
CMS Open Payments shows $20,378 in general payments to Dr. Bollard from 10 companies from 2017 to 2025. The largest total came from Swedish Orphan Biovitrum AB.
How long has Dr. Catherine Bollard been practicing?
Dr. Bollard graduated from medical school in 1991, 35 years ago.
Does Dr. Catherine Bollard do research?
Dmand AI links 267 publications to Dr. Bollard, published from 2003 to 2025. Dr. Bollard has worked on 10 clinical trials.
Who does Dr. Catherine Bollard publish with?
Dr. Bollard's most frequent co-authors are Helen E. Heslop, MD (62 shared papers), Malcolm Brenner, MD (36 shared papers) and Elizabeth J. Shpall, MD (33 shared papers).
What insurance does Dr. Catherine Bollard accept?
Dr. Bollard is in network with 4 carriers, including Blue Cross Blue Shield of Michigan, CareFirst BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in District of Columbia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card